eBioscience Licenses Anteo Diagnostics' Surface Coating Technology | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – eBioscience and Australian firm Anteo Diagnostics today announced a licensing deal covering Anteo's Mix&Go technology.

Anteo will supply eBioscience with its Mix&Go product for the manufacture of reagents. In return it will receive an initial upfront payment from eBioscience, fixed revenues for Mix&Go reagents supplied, and royalties on the sale of products by eBioscience using Mix&Go.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.